Tekmira Pharmaceuticals (TKMR) Stock Dives On Earnings Miss

Tekmira Pharmaceuticals Corp. (TKMR) stock took a dive in premarket trade Thursday after the company announced it missed its earnings estimates in the second quarter of the 2014 fiscal year. For 2Q ended June 30, the biotech company reported Q2 loss of ($0.28) per share versus ($0.30) consensus. The net loss for Q2’14 was 7 […] View the full post at: Tekmira Pharmaceuticals (TKMR) Stock Dives On Earnings Miss Related posts: Congress To Hold Hearing on the Circumstances Behind Thursday’s Stock Market Plunge Supervalu: An Aptly Named Stock Microsoft, Hewlett-Packard Increase Stock Buybacks